Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon.
作者信息
McDermott Amy
出版信息
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2107692118.
Abstract
摘要
相似文献
1
Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon.
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2107692118.
2
Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
Med J Aust. 2021 Nov 1;215(9):427-432. doi: 10.5694/mja2.51263. Epub 2021 Oct 11.
3
Impact of vaccination on the COVID-19 pandemic in U.S. states.
Sci Rep. 2022 Jan 28;12(1):1554. doi: 10.1038/s41598-022-05498-z.
4
The long road.
Science. 2021 Feb 19;371(6531):768-772. doi: 10.1126/science.371.6531.768.
5
COVID-19 vaccination for children: may be necessary for the full eradication of the disease.
Pediatr Res. 2021 Dec;90(6):1102-1103. doi: 10.1038/s41390-021-01643-y. Epub 2021 Jul 12.
6
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
7
How severe are Omicron infections?
Nature. 2021 Dec;600(7890):577-578. doi: 10.1038/d41586-021-03794-8.
8
Five reasons why COVID herd immunity is probably impossible.
Nature. 2021 Mar;591(7851):520-522. doi: 10.1038/d41586-021-00728-2.
9
Are COVID vaccination programmes working? Scientists seek first clues.
Nature. 2021 Jan;589(7843):504-505. doi: 10.1038/d41586-021-00140-w.
10
COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects.
Malays J Pathol. 2021 Aug;43(2):203-217.
引用本文的文献
1
What Lessons can Be Learned From the Management of the COVID-19 Pandemic?
Int J Public Health. 2025 May 30;70:1607727. doi: 10.3389/ijph.2025.1607727. eCollection 2025.
2
Biosafety and immunology: An interdisciplinary field for health priority.
Biosaf Health. 2024 Jul 14;6(5):310-318. doi: 10.1016/j.bsheal.2024.07.005. eCollection 2024 Oct.
3
Experiences and perceptions of migrant populations in South Africa on COVID-19 immunization: an interpretative phenomenological analysis.
BMC Public Health. 2024 Nov 12;24(1):3126. doi: 10.1186/s12889-024-20562-1.
4
Willingness-to-pay for COVID-19 vaccine in ten low-middle-income countries in Asia, Africa and South America: A cross-sectional study.
Narra J. 2022 Apr;2(1):e74. doi: 10.52225/narra.v2i1.74. Epub 2022 Apr 1.
5
Effective Vaccination and Education Strategies for Emerging Infectious Diseases Such as COVID-19.
J Korean Med Sci. 2023 Nov 13;38(44):e371. doi: 10.3346/jkms.2023.38.e371.
6
The spread of infectious diseases from a physics perspective.
Biol Methods Protoc. 2023 Jun 20;8(1):bpad010. doi: 10.1093/biomethods/bpad010. eCollection 2023.
7
Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria.
J Public Health Afr. 2023 May 4;14(5):2290. doi: 10.4081/jphia.2023.2290. eCollection 2023 Apr 30.
8
Microneedles: An Emerging Vaccine Delivery Tool and a Prospective Solution to the Challenges of SARS-CoV-2 Mass Vaccination.
Pharmaceutics. 2023 Apr 27;15(5):1349. doi: 10.3390/pharmaceutics15051349.
9
Clinical Course of 53 Previously Vaccinated Patients Admitted to the National Hospital in Warsaw, Poland with COVID-19 Between November 2021 and March 2022.
Med Sci Monit. 2023 Apr 29;29:e939841. doi: 10.12659/MSM.939841.
10
The language of vaccination campaigns during COVID-19.
Med Humanit. 2023 Sep;49(3):487-496. doi: 10.1136/medhum-2022-012583. Epub 2023 Apr 6.
本文引用的文献
1
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.
Science. 2021 May 21;372(6544):815-821. doi: 10.1126/science.abh2644. Epub 2021 Apr 14.
2
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.
MMWR Morb Mortal Wkly Rep. 2021 Apr 2;70(13):495-500. doi: 10.15585/mmwr.mm7013e3.
3
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study.
Lancet Microbe. 2021 Jun;2(6):e240-e249. doi: 10.1016/S2666-5247(21)00025-2. Epub 2021 Mar 23.
4
Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study.
Lancet. 2021 Mar 27;397(10280):1204-1212. doi: 10.1016/S0140-6736(21)00575-4. Epub 2021 Mar 17.
5
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
Cell. 2021 Apr 29;184(9):2372-2383.e9. doi: 10.1016/j.cell.2021.03.013. Epub 2021 Mar 12.
6
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.
Lancet. 2021 Feb 6;397(10273):452-455. doi: 10.1016/S0140-6736(21)00183-5. Epub 2021 Jan 27.
7
Immunological characteristics govern the transition of COVID-19 to endemicity.
Science. 2021 Feb 12;371(6530):741-745. doi: 10.1126/science.abe6522. Epub 2021 Jan 12.
8
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic.
Science. 2021 Jan 15;371(6526):288-292. doi: 10.1126/science.abe9728. Epub 2020 Dec 8.
9
Reproductive number of coronavirus: A systematic review and meta-analysis based on global level evidence.
PLoS One. 2020 Nov 11;15(11):e0242128. doi: 10.1371/journal.pone.0242128. eCollection 2020.
10
A history of herd immunity.
Lancet. 2020 Sep 19;396(10254):810-811. doi: 10.1016/S0140-6736(20)31924-3.
Zotero 插件